Skip to main content
. 2021 Feb 2;12(7):2010–2022. doi: 10.7150/jca.52578

Figure 4.

Figure 4

GPRC5A transcription in subgroups of patients with pancreatic cancer, stratified based on KRAS, TP53, SMAD4 and CDKN2A mutation. (A-D) Scatter plot showing expression of GPRC5A in normal individuals or PaCa patients with or without mutant KRAS (A), TP53 (B), SMAD4 (C) and CDKN2A (D). Data are mean ± SD. *, P < 0.05; **, P < 0.01; ***, P < 0.001.